Related Experiment Video

Updated: May 13, 2025

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

17.7K

10 tips on how to manage severe arrhythmia in haemodialysis patients

Eleni Stamellou1,2, Christos Georgopoulos1, Lampros Lakkas3

  • 1Department of Nephrology, University Hospital of Ioannina, Ioannina, Greece.

Clinical Kidney Journal
|April 14, 2025
PubMed

Insights

Cardiovascular disease and sudden cardiac death (SCD) are major risks for haemodialysis (HD) patients. This study offers 10 practical tips for clinicians to manage severe arrhythmias by addressing risk factors and promoting multidisciplinary care.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Medicine

Background:

  • Cardiovascular disease (CVD) is the primary cause of mortality in haemodialysis (HD) patients.
  • HD patients exhibit a significantly higher incidence of life-threatening ventricular arrhythmias and sudden cardiac death (SCD) compared to the general population.
  • Key risk factors include electrolyte imbalances, fluid overload, and ultrafiltration rates.

Purpose of the Study:

  • To provide practical guidance for clinicians managing severe arrhythmias in HD patients.
  • To emphasize the importance of addressing specific risk factors in HD-related arrhythmias.
  • To highlight the role of prevention and multidisciplinary care in reducing fatal arrhythmias.

Main Methods:

  • The study proposes 10 actionable tips for clinical management.
  • Focuses on identifying high-risk individuals for arrhythmias.
  • Emphasizes practical interventions and a multidisciplinary approach.

Main Results:

  • Clinicians can significantly reduce the risk of fatal arrhythmias.
  • Actionable insights are provided for managing severe arrhythmias.
  • Prevention strategies are detailed for high-risk HD patients.

Conclusions:

  • Effective management of arrhythmias in HD patients is achievable.
  • Addressing risk factors like electrolyte imbalances and fluid overload is crucial.
  • A multidisciplinary approach integrating prevention and practical interventions is key to improving outcomes for HD patients.

Keywords:
arrhythmiacardiovasculardialysispreventionsudden cardiac death

More Related Videos

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.4K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.1K

Related Concept Videos

Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
722
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
231
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
855
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
294
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
704